Capsid Fitness and Manufacturability
→ Simon Pacouret, …, Fatma Elzahraa Eid, Andrew Barry, Yujia Alina Chan, Ken Chan, Benjamin Deverman. A Modular Capsid Engineering Platform to Confer Neutralizing Antibody Evasion to CNS and muscle targeted AAVs. ASGCT, 2026.
→ Fatma Elzahraa Eid, Albert Chen, Ken Chan, Qin Huang, …, Benjamin E Deverman. The Machine Learning-Guided Fit4Function Platform Quantitatively Profiles the Biodistribution of Peptide-Modified AAV Capsids after a Single Round of Screening in Macaque. ASGCT, 2023.
→ Simon Pacouret, Fatma Elzahraa Eid, William Donahoe, Ken Y Chan, Jason Wu, Qingxia Zheng, Casey Keyes, Pamela Brauer, Albert Chen, Yujia A Chan, Benjamin Deverman. Development of Stabilized AAV Capsids for Vector Engineering. ASGCT, 2023.
→ Fatma Elzahraa Eid, Ken Y Chan, Albert T Chen, Qin Huang, …, Benjamin E Deverman. Fit4Function: A Machine Learning-Guided Approach for Systematic Multi-Trait AAV Capsid Engineering. ASGCT, 2022.
→ Fatma Elzahraa Eid, Ken Chan, Albert T Chen, Isabelle G Tobey, Qin Huang, Qingxia Zheng, Yujia Alina Chan, Ben Deverman. Machine Learning-Accelerated AAV Engineering through the Generation of Production-Fit Capsid Libraries. ASGCT, 2021.
AAV immunogenicity
→ Simon Pacouret, Ken Chan, …, Fatma Elzahraa Eid, Andrew Barry, Yujia Alina Chan, Benjamin Deverman. Antibody-evading AAV capsids compatible with CNS and muscle-targeting modifications. ASGCT, 2025.
→ Simon Pacouret, …, Fatma Elzahraa Eid, Andrew J Barry, Yujia A Chan, Ken Y Chan, Benjamin E Deverman. Engineering Human CNS Receptor-Targeted Capsids for Improved Antibody Evasion. ASGCT, 2024.
→ Simon Pacouret, Ken Y Chan, Fatma Elzahraa Eid, …, Benjamin E Deverman. Developing Blood-Brain Barrier-Crossing AAV9 Variants with Reduced Sensitivity to Neutralizing Antibodies. ASGCT, 2023.